Sapporo Clinical Laboratory (TSE:9776) 3-Year EBITDA Growth Rate : -6.80% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Sapporo Clinical Laboratory 3-Year EBITDA Growth Rate?

Sapporo Clinical Laboratory's EBITDA per Share for the three months ended in Mar. 2024 was 円27.57.

During the past 12 months, Sapporo Clinical Laboratory's average EBITDA Per Share Growth Rate was -23.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -6.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sapporo Clinical Laboratory was 50.00% per year. The lowest was -6.80% per year. And the median was 6.15% per year.

Competitive Comparison of Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate falls into.

Sapporo Clinical Laboratory 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sapporo Clinical Laboratory (TSE:9776) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sapporo Clinical Laboratory 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sapporo Clinical Laboratory's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sapporo Clinical Laboratory Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sapporo Clinical Laboratory Inc (TSE:9776) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

18-9-1 Nishi Kita-Gojo, Chuo-ku Sapporo, Hokkaido, Sapporo, JPN, 060 0005

Website

http://www.saturin.co.jp

Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.

Sapporo Clinical Laboratory Headlines

No Headlines